Special Issue on Non-Coding RNAs: Master Players in Several Pathological Conditions

Submission Deadline: Mar. 20, 2020

Please click the link to know more about Manuscript Preparation: http://www.clinexpmed.org/submission

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Rana Ahmed Youness Mohamed
      Department of Pharmaceutical Biology, Faculty of Pharmacy and Biotechnology, Cairo, Egypt
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Dr. Mamata Mishra
      Skin Regeneration and Stem Cell Therapy, National Burns Center, Navi Mumbai, Maharashtra, India
    • Reza Heidari
      Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Introduction

    Vast numbers of unique noncoding RNA (ncRNA) molecules have been identified within different cellular compartments. Previous work has shifted the perception of ncRNAs from 'junk' transcriptional products to functional regulatory molecules. ncRNAs could potentially modulate different cellular processes including chromatin re-modeling, transcription, post-transcriptional modifications and most importantly signal transduction through having hundreds of targets that could simultaneously affect, thus nominating ncRNAs to play a key role in the process of carcinogenesis. In terms of oncology, the most abundant and well studied ncRNAs are the small ncRNA molecules known as microRNAs (miRNAs/miRs) and the long ncRNA (lncRNA) molecules. Such ncRNAs have been identified as either oncogenic drivers or tumor suppressors in different malignancies. Of note, ncRNAs have been recently involved in a bi-directional crosstalk between several oncogenic signaling cascades. Thus, a deeper understanding of the complex networks of interactions that ncRNAs could coordinate and are involved in would provide a unique opportunity to design better therapeutic interventions.

    Aims and Scope:

    1. Role of microRNAs in Solid Malignancies
    2. Role of microRNAs in Hematological Malignancies
    3. Role of long non-coding RNAs in Solid Malignancies
    4. Role of long non-coding RNAs in Hematological Malignancies
    5. Role of piwi-RNAs in Health and disease
    6. Role of microRNAs in immunology
    7. Role of long non-coding RNAs in immunology

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.clinexpmed.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.